WHAT IS THE AIM OF THE DIRECTIVE?
Directive 2011/24/EU sets out the conditions under which a patient may travel to another European Union (EU) Member State / European Economic Area (EEA) country to receive safe and high-quality medical care and have the cost reimbursed by their own health insurance scheme. It also encourages cooperation between national healthcare systems.
KEY POINTS
-
The Member State providing the treatment must ensure that:
- all the information necessary is available for patients to make an informed choice, including on treatment options, availability, the quality and safety of the healthcare provided, prices, authorisation and registration status;
- transparent complaint procedures exist;
- professional liability insurance or similar guarantees are in place and appropriate to the nature and extent of the risk;
- privacy of personal data is respected, in line with EU rules on data protection;
- patients have access to a written or electronic record of the treatment they receive;
- patients must be treated on a non-discriminatory basis in relation to nationality;
- the scale of healthcare fees charged is the same as for domestic patients who are in a comparable medical situation, or the price charged is calculated according to objective, non-discriminatory criteria if there is no comparable price for domestic patients.
-
The Member State where the patient is insured must ensure that:
- the cost of the healthcare provided is reimbursed in accordance with Chapter III of the directive;
- information on patient rights and entitlements is available, including a clear distinction between the rights that patients have by virtue of this directive and rights arising from Regulation (EC) No 883/2004 (see summary);
- procedures for appeal and redress are available where patients consider that their rights have not been respected;
- patients have access to any necessary medical follow-up treatment as would have been provided if the healthcare had been received in its own territory;
- patients have access to their medical records.
- National contact points exist to provide information and to consult with patient organisations, healthcare providers and insurers.
-
Healthcare providers give all the necessary information to patients so they can make an informed decision, including:
- treatment options;
- availability;
- the quality and safety of the healthcare they provide;
- prices;
- authorisation or registration status.
- A patient’s own country must reimburse the cost of the treatment according to the scales that it applies domestically.
- A patient may require prior authorisation from their own country before going abroad for treatment. This may be necessary if the medical care involves at least one night in hospital and/or the use of highly specialised and cost-intensive medical equipment, or if it poses a particular risk for the patient or the population.
- A national authority may refuse to give prior authorisation if it considers that it can provide the patient with the necessary healthcare within a medically justifiable time limit.
- Requests for medical treatment abroad must be dealt with within a reasonable period of time.
- Prescriptions issued in one Member State should, in principle, be recognised in any other Member State, subject to certain conditions and exceptions.
- Member States / EEA countries and their competent authorities must cooperate in implementing the directive, including through mutual assistance and support for the European reference networks.
- The cooperation extends to tackling rare diseases.
- The legislation does not cover long-term care, the allocation of and access to organs for transplantation, or vaccinations.
- The directive does not affect how Member States organise and deliver healthcare or how they finance their national health systems for their own citizens.
- The European Commission must report on the operation of the directive periodically.
The Commission has adopted a number of implementing and delegated acts related to Directive 2011/24/EU. These include:
- Commission Implementing Directive 2012/52/EU on the recognition of medical prescriptions issued in another Member State;
- Commission Delegated Decision 2014/286/EU on criteria and conditions that European reference networks and healthcare providers wishing to join a European reference network must fulfil;
- Commission Implementing Decision 2014/287/EU on criteria for establishing and evaluating European reference networks and their members and for facilitating the exchange of information and expertise on establishing and evaluating such networks;
- Commission Implementing Decision (EU) 2019/1269 amending Implementing Decision 2014/287/EU on criteria for establishing and evaluating European reference networks and their members and for facilitating the exchange of information and expertise on establishing and evaluating such networks.
FROM WHEN DO THE RULES APPLY?
The directive had to be transposed into national law by 25 October 2013, and its rules have applied since that date.
The amendments introduced by Directive (EU) 2024/2839 entered into force on 27 November 2024.
BACKGROUND
- The rules on cross-border healthcare were clarified through the case-law of the Court of Justice of the European Union over a period of more than 10 years. Directive 2011/24/EU was adopted to clarify the rights to healthcare that derive from the Court’s rulings based on Article 56 of the Treaty on the Functioning of the European Union and to facilitate their practical exercise. The directive also aims to clarify its relationship with the existing framework established by Regulation (EC) No 883/2004 on the coordination of social security systems.
-
For further information, see:
MAIN DOCUMENT
Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross-border healthcare (OJ L 88, 4.4.2011, pp. 45–65).
Successive amendments to Directive 2011/24/EU have been incorporated into the original text. This consolidated version is of documentary value only.
RELATED DOCUMENTS
Report from the Commission on the operation of Directive 2011/24/EU on the application of patients’ rights in cross-border healthcare (COM(2022) 210 final).
Delegated Decision 2014/286/EU on criteria and conditions that EU reference networks and healthcare providers wishing to join a European reference network must fulfil.
Implementing Decision 2014/287/EU on criteria for establishing and evaluating EU reference networks and their members and for facilitating the exchange of information and expertise on establishing and evaluating such networks.
See consolidated version.
Implementing Directive 2012/52/EU on the recognition of medical prescriptions issued in another Member State.